Biotech: The Possibilities Are Endless

The best growth spots occur when the economy is at its lowest. Why? If you can see growth when the economy is at its worst, the future only gets better once the economy gets back on track. Biotechnology has the potential to be one of the best performing sectors over the next 4 to 8 years. Why just 4 to 8 years? Obama is expected to lift the ban on stem cell research this coming week. A potential second term for Obama could give biotech companies another 4 years to patent their drugs. With all the R&D expenses biotech companies inhibit, a continuation of the ban could put some of the smaller companies out of business as capital dries up. Renewed energy to research and develop drugs, along with a renewed economy in the next year, could bring unlimited profits over the next several years for this industry.

Cancer is set to replace heart disease as the number one killer of Americans in the next few years. Additional research in stem cells could put scientists closer to a cure. Research has already showed that stem cells can replace damaged or missing cells anywhere in the body. If stem cells could be manipulated to replace and rid the body of cancerous cells, the possibilities are endless. Putting moral convictions and emotion aside, the drugs made by stem cell companies would bring in huge profits. With the elderly being the single largest age group in America, these profits could last for the next decade should R&D continue without problem. Even in a bear market it is possible to make cash money. You just have to keep an open mind.